Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.970
+0.180 (+10.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,949,646
Open
1.805
Bid (Size)
1.930 (23)
Ask (Size)
2.020 (14)
Prev. Close
1.790
Today's Range
1.800 - 2.040
52wk Range
1.025 - 2.390
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Today 16:09 EDT
Via
Benzinga
ATAI Stock Earnings: ATAI Life Sciences Beats EPS, Misses Revenue for Q4 2023
Today 11:53 EDT
ATAI stock results show that ATAI Life Sciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
+16.57%
+16.57%
1 Month
+3.68%
+3.68%
3 Month
+27.10%
+27.10%
6 Month
+47.01%
+47.01%
1 Year
+48.12%
+48.12%
More News
Read More
Recap: ATAI Life Sciences Q4 Earnings
Today 7:55 EDT
Via
Benzinga
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
Today 7:00 EDT
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
March 27, 2024
From
atai Life Sciences
Via
GlobeNewswire
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
The Next Great Biotech Boom Has Arrived
March 19, 2024
Via
FinancialNewsMedia
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
March 16, 2024
Via
Benzinga
Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week
March 11, 2024
Via
Talk Markets
Exposures
Product Safety
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Via
Benzinga
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
March 04, 2024
From
atai Life Sciences
Via
GlobeNewswire
Largest Psychedelic Compound-Based Drug Stocks Up 15% In February; Now Up 33% YTD
March 01, 2024
Via
Talk Markets
atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
atai Life Sciences
Via
GlobeNewswire
Psychedelic Stocks Index Popped 8% Last Week, Led By Incannex
February 18, 2024
Via
Talk Markets
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Via
Benzinga
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
February 15, 2024
Via
Benzinga
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
February 06, 2024
From
atai Life Sciences
Via
GlobeNewswire
5 Largest Psychedelic Compound-Based Drug Stocks Up 17% Last Week
January 30, 2024
Via
Talk Markets
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
January 27, 2024
Via
Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Via
Benzinga
5 Largest Psychedelic Drug Stocks Advanced Slightly Last Week
January 13, 2024
Via
Talk Markets
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
January 24, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
January 12, 2024
Via
Benzinga
Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
January 09, 2024
Via
InvestorPlace
3 Big New Catalysts for Psychedelics Stocks in 2024
January 08, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.